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Abstract: BACKGROUND Left ventricular assist devices (LVAD) have become a common treatment
option in advanced heart failure. Lack of aortic valve opening during left ventricular unloading is a
common complication and associated with a worse outcome. Maintaining a minimum pulse pressure is
an important goal during the early postoperative period after LVAD implantation since it is commonly
seen as secure sign of aortic valve opening. AIMS/OBJECTIVE We report a case of an LVAD-supported
patient with early permanent closure of the aortic valve despite a pulse pressure > 15 mmHg at all times
following LVAD implantation. We demonstrate how careful assessment of the invasive arterial blood
pressure curve can indicate aortic valve closure irrespective of pulsatile blood flow. METHOD A 69-year
old male patient with terminal ischemic cardiomyopathy was referred for long-term mechanical circula-
tory support. Due to mild aortic regurgitation both an aortic bioprosthesis and a continuous-flow left
ventricular assist device were implanted. Postoperative echocardiography documented a patent aortic
bioprosthesis and an acceptable residual systolic left ventricular contractility. During invasive arterial
blood pressure monitoring repetitive transient slight blood pressure decreases followed by slight blood
pressure increases coincided with programmed LVAD flushing cycles. Permanent pulsatile flow with a
pulse pressure of ￿15 mmHg conveyed systolic opening of the aortic valve. Echocardiography, however,
proved early permanent aortic valve closure. In retrospect, transformation of the automated LVAD
flushing cycles into visible changes of the arterial blood pressure curve during invasive blood pressure
monitoring is indicative of ejection of the complete cardiac output through LVAD itself, and therefore
an early clinical sign of aortic valve closure. DISCUSSION/CONCLUSION We present this interesting
didactic case to highlight caveats during the early postoperative period after LVAD implantation. More-
over, this case demonstrates that careful and differentiated observation of the arterial blood pressure
waveform provides crucial information in this unique and growing patient population of continuous-flow
LVAD support.
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Abstract
Background: Left ventricular assist devices (LVAD) have become a common treatment option in advanced heart
failure. Lack of aortic valve opening during left ventricular unloading is a common complication and associated
with a worse outcome. Maintaining a minimum pulse pressure is an important goal during the early postoperative
period after LVAD implantation since it is commonly seen as secure sign of aortic valve opening.
Aims/objective: We report a case of an LVAD-supported patient with early permanent closure of the aortic valve
despite a pulse pressure > 15 mmHg at all times following LVAD implantation. We demonstrate how careful
assessment of the invasive arterial blood pressure curve can indicate aortic valve closure irrespective of pulsatile
blood flow.
Method: A 69-year old male patient with terminal ischemic cardiomyopathy was referred for long-term mechanical
circulatory support. Due to mild aortic regurgitation both an aortic bioprosthesis and a continuous-flow left
ventricular assist device were implanted. Postoperative echocardiography documented a patent aortic bioprosthesis
and an acceptable residual systolic left ventricular contractility. During invasive arterial blood pressure monitoring
repetitive transient slight blood pressure decreases followed by slight blood pressure increases coincided with
programmed LVAD flushing cycles. Permanent pulsatile flow with a pulse pressure of ≥15 mmHg conveyed systolic
opening of the aortic valve. Echocardiography, however, proved early permanent aortic valve closure. In retrospect,
transformation of the automated LVAD flushing cycles into visible changes of the arterial blood pressure curve
during invasive blood pressure monitoring is indicative of ejection of the complete cardiac output through LVAD
itself, and therefore an early clinical sign of aortic valve closure.
Discussion/conclusion: We present this interesting didactic case to highlight caveats during the early
postoperative period after LVAD implantation. Moreover, this case demonstrates that careful and differentiated
observation of the arterial blood pressure waveform provides crucial information in this unique and growing
patient population of continuous-flow LVAD support.
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Background/introduction
Mechanical circulatory support has advanced consider-
ably within the past two decades [1, 2]. As opposed to
first-generation pulsatile left ventricular assist devices
(LVAD) which mimicked a systole and diastole, similar
to native cardiac physiology, current second and third
generation continuous (non-pulsatile) flow devices are
much smaller and are associated with increased durabil-
ity [3]. Their impeller pumps generate continuous flow
that serves to continuously unload the left ventricle
(LV), from where blood flow is directed through an
extra-cardiac graft to the ascending aorta. While LV
pressure is reduced, there is an increase in pressure in
the ascending aorta, creating a continuous transvalvular
pressure gradient. Aortic valve (AV) opening occurs only
when left ventricular pressure exceeds the pressure in
the ascending aorta. Therefore, AV opening is thought
to depend on a) residual left ventricular contractility and
b) the amount of LVAD support (full vs. partial). Since
LVADs are frequently set to full support, specifically
when residual left ventricular contractility is poor, the
AV often remains closed throughout the cardiac cycle.
Over time, this may lead to valve thrombosis, commis-
sural fusion, reduced AV opening area and, in the long
run, to permanent AV closure or even aortic regurgita-
tion (AR) [4, 5]. Systolic AV opening, even if intermit-
tent, is associated with reduced thrombogenicity in the
aortic root area [6], which in turn may reduce the risk
for neurological events, which are among the most dev-
astating complications of long-term LVAD therapy. The
impact of AR in patients with continuous-flow LVAD
support is controversial [5]. Yet, AR reduces effective
cardiac output, thus elevating left ventricular filling pres-
sures, which may lead to recurrent heart failure symp-
toms [5, 7–10]. Therefore, in the early postoperative
phase, measures are taken to maintain systolic AV
opening during continuous-flow LVAD support by
carefully orchestrating medical inotropic support and
the amount of mechanical left ventricular unloading.
Routine invasive arterial blood pressure (BP) monitor-
ing allows assessing pulse pressure (systolic – dia-
stolic pressure) on a beat-to-beat basis [11]. A pulse
pressure of > 10 mmHg is targeted, as this is supposed
to indicate sufficient AV opening [12]. Here we
present a case, highlighting the limitations of this
monitoring in the early postoperative phase in the in-
tensive care setting.
Case presentation
A 69-year old diabetic male with ischemic heart disease,
severely reduced ejection fraction and surgical revascu-
larization with quadruple coronary artery bypass grafting
in 1997 presented to his family physician with nausea
and dyspnea for 24 h in late August 2016. A subacute
non-ST segment elevation myocardial infarction was di-
agnosed and partial thrombotic occlusion of the in-
ternal mammary bypass graft to the distal left
anterior descending coronary artery was identified as
culprit lesion. However, the remaining flow was re-
ported to be TIMI grade 3. The venous bypass graft
to the first diagonal branch was patent, whereas the
remaining venous grafts to the intermediate and the
posterior descending artery proved chronically oc-
cluded, as did all native coronary vessels. LV enddias-
tolic pressure (LVEDP) was severely increased (40
mmHg) and LV ejection fraction was below 15%. In
spite of increasing congestion of the spontaneously
breathing patient the remaining coronary flow was
judged sufficient, and a conservative medical manage-
ment was adjudicated and therapeutic anticoagulation
and dual antiplatelet therapy were initiated. After ini-
tial recompensation the patient experienced repetitive
hemodynamically relevant ventricular tachycardia that
could not be controlled with ICD- and medical ther-
apy and was associated with the repetitive need for
inotropic support (INTERMACS level 3) [13]. Conse-
quently, the patient was referred to our center for
evaluation of advanced heart failure therapy. Due to
coexistent severe cerebrovascular disease, chronic
renal impairment and his advanced age, the patient
was deemed ineligible for transplantation. Decision
for permanent mechanical circulatory support (destin-
ation therapy) using an LVAD was made. For pre-
existent mild aortic regurgitation a bioprosthetic AV
(Edwards Perimount Magna 3000) was implanted
along with a third-generation, continuous-flow LVAD
(HeartWare, Framingham, MA). Initial postoperative
echocardiography documented a normally working
aortic bioprosthesis. Pulse pressure, as assessed by in-
vasive arterial BP monitoring, was constantly ≥15
mmHg. At postoperative day 7 hemodynamic moni-
toring showed a repetitive distinct pattern with a brief
decrease followed by a transient increase in peripheral
arterial BP (Fig. 1a). This pattern occurred every 60 s
and coincided with the LVAD flushing cycle. On
close observation of the arterial BP waveform, no di-
crotic notch was visible between systolic decline and
diastolic runoff. Echocardiography testified permanent
AV closure despite a residual LV ejection fraction of
15 to 20% (Fig. 2).
Discussion and conclusion
We present a case of continuous-flow LVAD support
in a patient with ischemic cardiomyopathy. Even
though systolic contractility of the unloaded LV was
sufficient to generate pulsatile blood flow, 7 days after
LVAD and bioprosthetic AV implantation, no more
systolic AV opening could be documented. This
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finding was evident by transformation of LVAD flush-
ing cycles into systemic BP changes during preserved
pulse pressure ≥ 15 mmHg as assessed by invasive ar-
terial monitoring. The flushing cycle encompasses a
reduction of the pump speed by 200 rpm below the
set speed for 2 seconds, followed by an increased
pump speed to 200 rpm above the set speed for 1 sec-
ond before the pump returns to the programmed
speed (Fig. 1b). This maneuver is routinely applied in
order to prevent clot formation and pump throm-
bosis. Under normal conditions, pulsatile blood flow,
generated by residual systolic contraction of the
unloaded left ventricle and consecutive ejection
through a patent AV, masks these brief LVAD flush-
ing cycles. In the absence of systolic AV opening, sys-
tolic ejection is possible through secondary and
tertiary, passive LVAD blood flow paths, which are
partially independent of impeller position and speed
[14]. Thus, LVAD flushing cycles become apparent as
visible transient decrease followed by a brief increase
in BP on invasive BP monitoring. Transformation of the
LVAD flushing cycle into a visible change in peripheral ar-
terial BP in presence of pulsatile blood flow (preserved
pulse pressure > 10mmHg), therefore indicates systolic
ejection from the LV exclusively through the apical LVAD
while the AV remains closed.
In summary, the presence of pulsatile blood flow alone
is insufficient proof of a patent aortic valve during
continuous-flow LVAD support. Even in presence of
remaining LV contractility, permanent AV closure may
occur. However, transmission of LVAD flushing cycles
and disappearance of the dicrotic notch in the arterial
blood pressure waveform may hint toward AV closure
early after continuous-flow LVAD implantation. Careful
observation of the arterial blood pressure waveform
during the early postoperative phase may provide highly
relevant information on both cardiac function and
valvular mechanics.
Fig. 1 Invasive arterial blood pressure tracing and LVAD flushing
cycle. Timely coincidence of a transient arterial blood pressure
reduction, followed by a brief increase, as assessed by invasive radial
blood pressure monitoring (a), with the LVAD flushing cycle
(scheme, rpm = rotations per minute) (b). Importantly, the flushing
cycle transforms into a detectable change in peripheral blood
pressure in presence of pulsatile blood flow, indicating left
ventricular ejection through the apical inflow cannula and, thus,
closure of the aortic valve during the complete cardiac cycle.
LVAD = left ventricular assist device
Fig. 2 Transthoracic echocardiography. Transthoracic echocardiography on postoperative day 7 showing the closed aortic valve prosthesis in
parasternal long axis view (A-D). a Zoom on aortic valve prosthesis. b Color Doppler showing continuous flow in the extracardiac graft (*)
anastomosing into the ascending aorta. c Color Doppler showing flow on both sides of the closed aortic valve prosthesis. d M-mode tracing
without opening of the aortic valve prosthesis throughout the cardiac cycle
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